Centrum Medyczne ENEL-MED (WAR:ENE) DeferredTaxAndRevenue: zł0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:ENE Centrum Medyczne ENEL-MED SA WAR:ENE
78 GF Score
Price zł19.00
GF Value zł25.19
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Centrum Medyczne ENEL-MED DeferredTaxAndRevenue?

Centrum Medyczne ENEL-MED WAR:ENE -0.52% 78 DeferredTaxAndRevenue is zł0.0 Mil as of Mar. 2026. GuruFocus rates WAR:ENE with a GF Score™ of 78/100 and a GF Value™ of zł25.19 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Centrum Medyczne ENEL-MED's current deferred tax and revenue for the quarter that ended in Mar. 2026 was zł0.0 Mil.

Centrum Medyczne ENEL-MED DeferredTaxAndRevenue Related Terms


Centrum Medyczne ENEL-MED DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Centrum Medyczne ENEL-MED's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Centrum Medyczne ENEL-MED DeferredTaxAndRevenue Chart

Centrum Medyczne ENEL-MED Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Centrum Medyczne ENEL-MED Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WAR:ENE
78GF Score
Centrum Medyczne ENEL-MED SA WAR:ENE
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of zł0.0 Mil mean?
Centrum Medyczne ENEL-MED (WAR:ENE) has a DeferredTaxAndRevenue of zł0.0 Mil as of Mar. 2026. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Centrum Medyczne ENEL-MED.
Is Centrum Medyczne ENEL-MED's DeferredTaxAndRevenue too high?
Centrum Medyczne ENEL-MED's current DeferredTaxAndRevenue is zł0.0 Mil. Overall, Centrum Medyczne ENEL-MED has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Centrum Medyczne ENEL-MED's DeferredTaxAndRevenue compare to HCA and THC?
Centrum Medyczne ENEL-MED's DeferredTaxAndRevenue of zł0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Healthcare Providers & Services company?
A good DeferredTaxAndRevenue depends on the Healthcare Providers & Services industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Centrum Medyczne ENEL-MED. Centrum Medyczne ENEL-MED's current DeferredTaxAndRevenue is zł0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Centrum Medyczne ENEL-MED stock overvalued right now?
Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED (WAR:ENE) is currently considered Modestly Undervalued. The stock's GF Value™ is zł25.19, compared to a current price of zł19.00 — trading 24.6% below its estimated fair value. The current DeferredTaxAndRevenue is zł0.0 Mil. Centrum Medyczne ENEL-MED's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Centrum Medyczne ENEL-MED (WAR:ENE), the current DeferredTaxAndRevenue is zł0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Centrum Medyczne ENEL-MED (WAR:ENE) Overvalued in 2026?

Based on GuruFocus' analysis, Centrum Medyczne ENEL-MED stock appears to be undervalued. The current stock price of zł19.00 is trading 24.6% below its estimated GF Value™ of zł25.19. GuruFocus considers Centrum Medyczne ENEL-MED to be Modestly Undervalued.

Key valuation signals for WAR:ENE:

  • DeferredTaxAndRevenue: zł0.0 Mil
  • GF Value™: zł25.19 vs. price of zł19.00 (24.6% below fair value)
  • GF Score™: 78/100 with 5 warning signs

No single metric tells the full story. See the WAR:ENE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Centrum Medyczne ENEL-MED Business Description

Address ul. Slominskiego 19 lok. 524, Warsaw, POL, 00-195
Centrum Medyczne ENEL-MED SA is engaged in providing medical services throughout Poland region. The company is involved in providing various services that are dentistry, picture diagnosis, clinics, subscription for companies, and medical insurance. It also provides hospitals, aesthetic medicines, and sports medicine. The company's treatment cycle consists of consultation, diagnosis, hospitalization, surgery, and rehabilitation.
78GF Score

Get the complete analysis for WAR:ENE

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł19.00
Price
zł25.19
GF Value